Literature DB >> 22441653

Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

Benjamin Descours1, Veronique Avettand-Fenoel, Catherine Blanc, Assia Samri, Adeline Mélard, Virginie Supervie, Ioannis Theodorou, Guislaine Carcelain, Christine Rouzioux, Brigitte Autran.   

Abstract

BACKGROUND: The stable immune control of human immunodeficiency virus (HIV) in long-term nonprogressors (LTNPs) with protective human leukocyte antigen (HLA) alleles raises the question of whether and how these alleles influence the immune distribution of the HIV reservoirs.
METHODS: Cell-associated HIV-DNA levels were quantified in blood sorted resting CD4 T-cell subsets from 8 LTNPs with and 10 without HLA-B*27 or HLA-B*57 alleles (HLA-B27/B57).
RESULTS: A remarkably lower infection level of central memory CD4 T cells (T(CM)) was an exclusive feature that distinguished the HLA-B27/B57 HIV reservoirs from the other ones. In LTNPs, T(CM) protection was correlated with preservation of T(CM) counts, which correlated positively with the magnitude of HIV Gag-specific CD8 T cells. In HLA-B27/B57 LTNPs, a lower activation level of their memory CD4 T cells was associated with lower amounts of cell HIV-DNA in each resting memory CD4 subset and were also associated with higher ratios of HIV Gag-specific CD8 T cells per infected resting CD4 T cell (effector/target [E/T]). As a result, HLA-B27/B57 E/T ratios were negatively correlated with the contribution of memory CD4 T-cell subsets to the total HIV reservoirs.
CONCLUSIONS: The potent antiviral immunity governed by the protective HLA-B27/B57 alleles, by limiting T(CM) infection and pool exhaustion, are associated with a reduced T(CM) contribution to the HIV reservoir.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22441653     DOI: 10.1093/cid/cis188

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

Review 1.  Post-Treatment Controllers: Role in HIV "Cure" Research.

Authors:  Leslie R Cockerham; Hiroyu Hatano; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  Early treatment and HIV-1 reservoirs: a stitch in time?

Authors:  Timothy J Henrich; Rajesh T Gandhi
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

3.  Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.

Authors:  Marilia Rita Pinzone; Erin Graf; Lindsay Lynch; Brigit McLaughlin; Frederick M Hecht; Mark Connors; Stephen A Migueles; Wei-Ting Hwang; Giuseppe Nunnari; Una O'Doherty
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

5.  CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection.

Authors:  Samantha J Westrop; Graeme Moyle; Akil Jackson; Mark Nelson; Sundhiya Mandalia; Nesrina Imami
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

6.  MicroRNA-155 Reinforces HIV Latency.

Authors:  Debbie S Ruelas; Jonathan K Chan; Eugene Oh; Amy J Heidersbach; Andrew M Hebbeler; Leonard Chavez; Eric Verdin; Michael Rape; Warner C Greene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

7.  CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals.

Authors:  Anabela C P Picton; Maria Paximadis; Richard E Chaisson; Neil A Martinson; Caroline T Tiemessen
Journal:  Clin Immunol       Date:  2017-04-18       Impact factor: 3.969

Review 8.  Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.

Authors:  Christine Katlama; Steven G Deeks; Brigitte Autran; Javier Martinez-Picado; Jan van Lunzen; Christine Rouzioux; Michael Miller; Stefano Vella; Joern E Schmitz; Jeffrey Ahlers; Douglas D Richman; Rafick P Sekaly
Journal:  Lancet       Date:  2013-03-29       Impact factor: 79.321

9.  Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.

Authors:  Jonathan Z Li; Andrea Heisey; Hayat Ahmed; Hongying Wang; Lu Zheng; Mary Carrington; Terri Wrin; Robert T Schooley; Michael M Lederman; Daniel R Kuritzkes
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

10.  Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.

Authors:  Maria J Buzon; Enrique Martin-Gayo; Florencia Pereyra; Zhengyu Ouyang; Hong Sun; Jonathan Z Li; Michael Piovoso; Amy Shaw; Judith Dalmau; Nadine Zangger; Javier Martinez-Picado; Ryan Zurakowski; Xu G Yu; Amalio Telenti; Bruce D Walker; Eric S Rosenberg; Mathias Lichterfeld
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.